Bupropion XR Sandoz 150 mg Retardtabletten

Country: Շվեյցարիա

language: գերմաներեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

bupropioni hydrochloridum

MAH:

Sandoz Pharmaceuticals AG

ATC_code:

N06AX12

INN:

bupropioni hydrochloridum

pharmaceutical_form:

Retardtabletten

composition:

bupropioni hydrochloridum 150 mg, povidonum K 90, acidum hydrochloridum, natrii stearylis fumaras corresp. natrium 0.309 mg, ethylcellulosum, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, silica colloidalis anhydrica, macrogolum 1500, triethylis citras, Überzug: hypromellosum, macrogolum 400, macrogolum 8000, pro compresso obducto.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

Antidepressivum

authorization_status:

zugelassen

authorization_date:

2023-12-12